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T cell sensitivity to antigen is intrinsically regu-
lated during maturation to ensure proper devel-
opment of immunity and tolerance, but how this
is accomplished remains elusive. Here we show
that increasing miR-181a expression in mature
T cells augments the sensitivity to peptide anti-
gens, while inhibiting miR-181a expression in
the immature T cells reduces sensitivity and
impairs both positive and negative selection.
Moreover, quantitative regulation of T cell sen-
sitivity by miR-181a enables mature T cells to
recognize antagonists—the inhibitory peptide
antigens—as agonists. These effects are in
part achieved by the downregulation of multiple
phosphatases, which leads to elevated steady-
state levels of phosphorylated intermediates
and a reduction of the T cell receptor signaling
threshold. Importantly, higher miR-181a ex-
pression correlates with greater T cell sen-
sitivity in immature T cells, suggesting that
miR-181a acts as an intrinsic antigen sensitivity
‘‘rheostat’’ during T cell development.
INTRODUCTION
One of the key features of a functioning immune system is
its ability to distinguish antigens of foreign origin from
those derived endogenously and to mount an immune re-
sponse against the former. With respect to T cells, this
goal is achieved through antigen recognition by T cell re-
ceptors (TCRs) and a highly ordered developmental pro-
cess in the thymus. TCRs constantly sample a diverse
set of self and foreign peptide antigens presented in majorhistocompatibility complexes (MHCs) on the surface of
antigen presenting cells (APCs), and these interactions
elicit discrete intracellular signals and T cell responses.
The mature T cell’s response to antigen is largely dictated
by the binding characteristics of its TCR for a given pep-
tide-MHC complex (pMHC) (Kersh and Allen, 1996). In
general, pMHC ligands with slower dissociation rates pro-
duce stronger TCR signals and lead to higher T cell reac-
tivity to the antigenic peptides (Davis et al., 1998; Holler
and Kranz, 2003). Typically, the most stable pMHC com-
plexes with respect to TCR binding are agonists, while
the less stable variants are weak agonists and then
antagonists (Lyons et al., 1996; Wu et al., 2002), which
are not able to activate T cells more than partially
themselves (Sumen et al., 2004) and also block responses
to agonist ligand (De Magistris et al., 1992). Although
a number of models have been proposed to explain this
kinetic discrimination in T cell activation (McKeithan,
1995; Rabinowitz et al., 1996), exactly how T cells sense
quantitative changes in antigenic peptide affinities
through their TCRs and produce both quantitatively and
qualitatively different responses remains an intensive
area of study.
In addition, T cell responsiveness and TCR signaling to
a specific ligand also vary with different developmental
stages, suggesting that T cell sensitivity to antigens is in-
trinsically regulated during development (Davey et al.,
1998). For example, in immature CD4+CD8+ double-
positive (DP) thymocytes, low affinity antigenic peptides
that are unable to activate mature effector T cells are
sufficient to induce strong activation and clonal deletion
(Pircher et al., 1991); antagonists that are normally inhibi-
tory to effector T cells can induce positive selection
(Hogquist et al., 1994). These observations demonstrate
that T cell sensitivity is intrinsically regulated to ensure
proper development of specificity and sensitivity to for-
eign antigens while avoiding self recognition. However,Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 147
Figure 1. Effects of miR-181a on Agonist Stimulated T Cell Calcium Response
(A) Developmental regulation of miR-181a expression in various purified T cell populations determined by miRNA qPCR.
(B) qPCR analysis of miR-181a ectopic expression in primed T cells.
(C and D) Calcium flux in T cells ectopically expressing control (C) or miR-181a virus (D) in response to a defined number of agonist MCC peptides. In
the top left are peptide images representing the integrated intensity of six MCC peptides at the T cell and APC (T:APC) interface. Shown in the bottom
left is relative cytosolic calcium concentration as a function of time after stimulation, as measured from ratioed fura-2 images; the arrow indicates the
time point at which the peptide image was taken. In the top right are overlaid differential interference contrast (DIC) images and ratioed calcium
images taken at different time points after stimulation. In the bottom right are corresponding ratioed calcium images. Fluorescence intensity of
the calcium signal is represented in a false color scale.148 Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc.
little is known about how intrinsic molecular programs in-
fluence this sensitivity.
Recent studies suggest that microRNA (miRNA)-medi-
ated gene regulation may represent a fundamental layer
of posttranscriptional genetic programs in metazoan
genomes that has broad effects on gene expression
(Ambros, 2003; Bartel, 2004). These 22 nt RNAs can re-
press the expression of protein-coding genes by targeting
cognate messenger RNAs for degradation or translational
repression (Ambros, 2003; Bartel and Chen, 2004). Many
miRNAs are differentially regulated in hematopoietic line-
ages, and some have been shown to play roles in control-
ling the development of immune cells (Chen et al., 2004;
Fazi et al., 2005). However, the role of miRNAs in the adap-
tive immune response is largely unknown.
RESULTS
Dynamic Regulation of miR-181a Expression
during T Cell Development
Among many known hematopoietic miRNAs, miR-181a
was shown to have a role in B and T cell differentiation
when ectopically expressed in hematopoietic stem/pro-
genitor cells (Chen et al., 2004). Interestingly, miR-181a
is also strongly expressed in the mouse thymus. To char-
acterize the role of miR-181a in T cells, we examined how
miR-181a expression is regulated during T cell develop-
ment and maturation. T cell differentiation in the thymus
can be divided into discrete stages characterized by the
expression of CD4 and CD8 coreceptors. CD4 and CD8
double-negative (DN) cells, which are the early T cell pro-
genitors, can differentiate into CD4 and CD8 DP cells and
then CD4 or CD8 single-positive (SP) cells. DN cells can be
further fractionated based on the expression of CD44 and
CD25 into DN1 (CD44+ CD25), DN2 (CD44+ CD25+), DN3
(CD44 CD25+), and DN4 (CD44CD25) cell popula-
tions, in the order of their appearance during develop-
ment. We purified these populations by FACS sorting ac-
cording to surface marker expression. We also obtained
CD4+ naı¨ve T cells from the lymph nodes of Rag2/
5C.C7 TCR transgenic mice and derived Th1 and Th2 ef-
fector cells. Analysis of miR-181a expression in these
populations revealed a dynamic regulation of miR-181a
expression during T cell maturation (Figure 1A).
miR-181a expression is high in the early T cell differen-
tiation stages ranging from approximately 427 to 858 to
1077 copies/cell in the DN1-3 cell populations, respec-
tively. Its expression then drops sharply to 225, 141,
42, and 14 copies/cell in DN4, DP, CD4 SP, and CD8 SP
thymocytes. We also noticed a further decrease to 29
copies/cell in naı¨ve cells, and 12 and 8 copies/cell in
Th1 and Th2 cells (Figure 1A). Notably, when comparingto effector T cells and taking into account that DP cells
are much smaller in size, miR-181a expression is signifi-
cantly higher in DP cells, which are more sensitive to
pMHCs with low or intermediate affinities. In comparison,
miR-142-3p, a hematopoietic-specific miRNA (Chen et al.,
2004), has distinct expression patterns during T cell devel-
opment and maturation (Figure S1A). The dynamic regula-
tion of miR-181a expression indicates that miR-181a may
play a role in T cell maturation. Indeed, using an OP9-DL1
stromal cell and thymocyte coculture assay (Schmitt et al.,
2004), we have shown that ectopic expression of miR-
181a in DN thymocytes causes a quantitative increase in
the percentage of DP cells and a decrease in the propor-
tion of CD8+ SP cells (H.M., T. Mao, and C.-Z.C., unpub-
lished data), suggesting that miR-181a can influence the
development of thymic progenitor cells during both pre-
TCR and TCR-dependent stages.
miR-181a Augments TCR Signaling Strength
To investigate miR-181a’s role in antigen recognition, we
assessed its effect on TCR signaling in antigen-primed
CD4+ T cells. We increased the expression of miR-181a
in primed T cells derived from 5C.C7 TCR transgenic
mice by retroviral transduction (Figure S2A), and this re-
sulted in an approximately 3- to 5-fold elevation in miR-
181a levels (Figure 1B). T cells were then stimulated with
CH27 APCs preloaded with a nonsaturating amount of ag-
onist peptide derived from Moth Cytochrome C (MCC,
amino acids 88–103), and then TCR signaling strength
was assessed by measuring calcium elevation using video
microscopy and ratio imaging. Elevated miR-181a ex-
pression in T cells resulted in a substantial increase in
intracellular calcium upon stimulation by MCC, whereas
mutations in the 50 two and three nucleotides of miR-
181a reduced this activity nearly to the basal level (Fig-
ure S3). Furthermore, miR-181a expression in T cells in-
creased IL-2 production by 2-fold compared to the control
(Figure 2D). These results show that increased miR-181a
expression augments TCR-mediated T cell activation.
We then measured the effects of miR-181a on TCR sig-
nal output at the single cell level (Figures 1C and 1D;
Movies S1 and S2). The TCR signal input is defined as
the number of antigenic pMHC complexes at the T:APC
interface, and the output is measured as the calcium con-
centration changes in the T cell cytosol (Irvine et al., 2002;
Li et al., 2004; Purbhoo et al., 2004). In T cells infected with
control virus (control T cells), approximately five MCC
peptides are needed to produce a half-maximal calcium
response (EC50) (Figures 1C and 1E). This response is es-
sentially identical to that of uninfected T cells (Irvine et al.,
2002; Li et al., 2004), suggesting that viral infection did
not cause discernable changes in TCR signaling. In(E) Integrated calcium signals as a function of defined number of MCC ligands. Each data point represents the average calcium signals of three or
more responding T cells. Lines are fitted with the same sigmoidal dose-response (variable slope) equation. The dashed lines indicate the number
of peptides required to reach half-maximal calcium responses. The double arrow illustrates the absolute increase of the calcium signal plateau.
(F) Effects of miR-181a on T cell calcium responses to APCs preloaded with various concentrations of the weak agonist MCC 102S (averaged inte-
grated calcium value ± SD, n = 30). All error bars in this figure are standard deviation (SD).Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 149
Figure 2. Effects of miR-181a on Antagonist Function
(A and B) Overlaid DIC and calcium images taken at various time points after control (top panel) or miR-181a T cells (lower panel) were stimulated with
APCs preloaded with (A) mixed agonist MCC (0.1 mM) and antagonist MCC 99R (20 mM) or (B) MCC 99R (20 mM) alone.
(C) Average calcium level was plotted against time. Each data point represents the average calcium level of 30 or more responding T cells in each of
the experimental groups.
(D and E) Induction of IL-2 production and (E) proliferation by MCC 99R. Primed T cells were cocultured with g-irradiated CH27 cells preloaded with
either the null peptide MCC 99A (10 mM), MCC 99R (10 mM), or MCC (1 mM) supernatants were collected at 24 hr after stimulation and analyzed for IL-2
production ([IL-2] ± SD, n = 3) (D).
(E) Primed T cells were stimulated in (D) for CSFE assay. The percentage of T cells undergoing proliferation was calculated as described (Gudmunds-
dottir et al., 1999). Representative experiments of three independent analyses are shown.
(F) Effects of miR-181a on T cell calcium responses to the antagonist 102G (fura ratio ± SD, n = 30).150 Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc.
comparison, T cells transduced with the miR-181a con-
struct (miR-181a T cells) require only approximately two
MCC peptides to reach the EC50 (Figures 1D and 1E),
showing that miR-181a expression increases T cell sensi-
tivity by more than 2-fold. Also notable is that signal output
in miR-181a T cells is about 40% higher than that in control
T cells, as indicated by the plateau calcium flux (Figure 1E).
The effects of miR-181a may be understated in this mea-
surement since MCC is a strong agonist and may allow lit-
tle room for further improvement. Indeed, a more dramatic
increase was observed when miR-181a T cells were chal-
lenged with a weak agonist, MCC 102S (Figure 1F). These
observations demonstrate that miR-181a expression in
mature T cells augments both the strength and sensitivity
of TCR signaling to strong and weak agonists.
miR-181a Converts Antagonists into Agonists
In addition to these quantitative changes in T cell sen-
sitivity, we also explored whether miR-181a could alter
antigen discrimination and allow T cells to respond to an-
tagonists. Under standard test conditions, when the an-
tagonist MCC 99R is present in large excess to the agonist
(Sumen et al., 2004), TCR signaling is blocked in control T
cells—where no calcium influx was detected (Figure 2A).
Interestingly, under the same conditions, TCR signaling
is not blocked in miR-181a T cells, demonstrating that
miR-181a overrides TCR antagonism (Figure 2A; Movie
S3). Since we have shown that miR-181a expression
can augment the TCR response to agonists (Figure 1), it
was possible that this reversal of antagonist function sim-
ply is the result of increased agonist responses beyond
the ability of antagonist to block. However, when T cells
were challenged with antagonist alone, we found that
MCC 99R can stimulate a calcium response in miR-181a
T cells, demonstrating that miR-181a expression enables
T cells to recognize the normally inhibitory antagonist as
an agonist (Figure 2B; Movie S4). MCC 99R stimulation re-
sulted in a more than 2-fold increase of calcium in the peak
response and sustained elevation for more than 10 min, in-
dicating that the antagonist induces a full-scale response
in these cells (Figure 2C).
Furthermore, we examined whether MCC 99R can stim-
ulate effector T cell function. In miR-181a T cells, MCC 99R
is able to stimulate IL-2 production (Figure 2D) and T cell
proliferation (Figure 2E), although somewhat more weakly
than the responses generated by MCC in control cells.
Moreover, this dramatic functional switch is not limited
just to MCC 99R: similar results are seen with another an-
tagonist, MCC 102G (Figures 2F and 6E). Taken together,
these results show that ectopic miR-181a expression not
only quantitatively enhances T cell signaling strength and
TCR sensitivity to antigens but also leads to a qualitative
switch and enables them to respond to antagonists.
miR-181a Represses Multiple Negative Regulators
in the TCR Signaling Pathway
To understand how miR-181a influences T cell reactivity,
we first examined whether miR-181a regulates the ex-pression of 5C.C7 TCR or other surface molecules that
are known to play important roles in TCR signaling. miR-
181a expression does not change TCR density on the
cell surface based on FACS analysis (Figure S4A). Further-
more, there is no discernable difference in surface CD4
levels (Figure S4A), thus eliminating the possibility that
miR-181a augments T cell sensitivity by altering CD4 cor-
eceptor expression (Irvine et al., 2002; Li et al., 2004). In-
terestingly, we did detect an increase in the costimulatory
molecule CD28 and a decrease in its antagonistic partner
CTLA-4 on miR-181a T cells (Figure S4B). Modulating the
expression of costimulatory molecules by miR-181a
seems to have a positive effect on TCR signal strength
as indicated by sustained calcium flux (Figures S4C and
S4D), which may have contributed to the plateau elevation
observed in Figure 1E. However, miR-181a T cells can still
respond to MCC 99R while costimulation is inhibited by
antibody blockade of CD28 ligands (B7.1 and B7.2) on
the APCs’ surface, indicating that miR181a’s effect on
costimulation does not contribute to the conversion of an-
tagonists to agonists (Figure S5; Movie S5). Thus, miR-
181a is more likely to modulate TCR sensitivity to antigens
by controlling the expression of intracellular signaling
molecules.
By challenging T cell clones bearing two distinct TCRs
with their respective peptide agonist and antagonist, sev-
eral studies have shown that antagonists elicit negative
signals that can actively repress the agonist-induced re-
sponses from the other TCR (Dittel et al., 1999). The tyro-
sine phosphatase SHP-1 has been proposed to be the
negative feedback regulator triggered by antagonists,
and the activation of ERK kinases appears to override
this suppression (Dittel et al., 1999; Stefanova et al.,
2003; Altan-Bonnet and Germain, 2005). However, our
computational analysis does not shown any putative
miR-181a binding sites in the SHP-1 mRNA. Furthermore,
miR-181a expression in T cells does not alter SHP-1 pro-
tein (Figure 3B) or RNA level (Figure 3C). Thus, SHP-1 is
not a direct target of miR-181a, suggesting that other
components of the T cell signaling pathway may contrib-
ute to antagonism.
Since a number of tyrosine and serine phosphatases
besides SHP-1 have been implicated in the suppression
of TCR signaling (Mustelin et al., 2005), we examined po-
tential miR-181a target sites in the phosphatases that
might be involved in TCR proximal signaling (nonreceptor
type tyrosine phosphatases, PTPNs) or ERK dephosphor-
ylation (dual specificity phosphatases, DUSPs). We
searched for potential miR-181a pairing sites in function-
ally relevant candidate genes using an unpublished com-
puter program (J.C. and C.-Z.C., unpublished data). In
brief, candidate mRNA sequences are broken into 40 nt
overlapping fragments, and their ability to pair with miR-
181a is analyzed using the RNA folding program M-
FOLD. Target sequences that form more stable pairing
with self than with miR-181a are eliminated: in this way,
our program takes into consideration the secondary struc-
ture of the target sites. Furthermore, single nucleotideCell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 151
Figure 3. miR-181a Represses Multiple Phosphatases in T Cells
(A) Effects of miR-181a and miR-181amut expression on luciferase reporter constructs containing putative miR-181a target sites are shown as relative
luciferase activity (normalized to the Rennilla control and compared to the control reporter vector). Representative analyses of four independent
experiments are shown (relative luciferase activity ± SD, n = 3; student’s t test, **: p < 0.01).
(B and C) miR-181a regulation of phosphatase expression at the protein and mRNA levels.
(B) Relative protein levels were determined by densitometry and normalized to b-actin, the loading control.
(C) miRNA-181a effect on mRNA level of each target is shown as the relative level toward the control virus after normalization to b-actin. Represen-
tative results of three independent experiments are shown (relative mRNA level ± SD, n = 3).mismatch and G:U base pairing in the seed region is
tolerated, since these are features of many genetically
validated target sites (Reinhart et al., 2000; Didiano and
Hobert, 2006). Both the coding regions and the untrans-
lated regions (UTRs) of the candidate targets are ana-
lyzed.
Using this program, we found that the tyrosine phos-
phatases SHP-2 and PTPN22 and the ERK-specific
phosphatases DUSP5 and DUSP6 each contain multiple
putative miR-181a pairing sites (Figure S6). Only DUSP6152 Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc.was predicted as a miR-181a target by published compu-
tational methods (Krek et al., 2005; Lewis et al., 2005).
Those potential target sites with near-perfect seed pairing
and/or the lowest calculated free energy of binding were
selected for further validation using a luciferase reporter
assay (Figure S6). Fusion luciferase reporters bearing pre-
dicted target sequences from SHP-2, PTPN22,DUSP5, or
DUSP6, respectively, were specifically repressed by
miR-181a, but not by an miR-181a mutant (Figure 3A) or
miR-142 (data not shown). Furthermore, western blot
revealed that SHP-2, PTPN22, DUSP5, and DUSP6
protein levels are quantitatively reduced by miR-181a,
but not by an miR-181a mutant (Figure 3B). Finally, miR-
181a can also reduce the mRNA levels of the target genes
in T cells as indicated by qPCR analyses (Figure 3C).
These results suggest that miR-181a may directly repress
the expression of multiple phosphatases.
miR-181a Expression Enhances the Basal Activation
of TCR Signaling Molecules
Downregulation of these phosphatases by miR-181a is
likely to systematically reduce negative feedback at dis-
tinct steps of TCR signaling. PTPN22, a potent negative
regulator immediately downstream of TCR (Hasegawa
et al., 2004), can dephosphorylate Lck and ZAP70 at the
activating Y394 and Y493 within the kinase activation
loops (Wu et al., 2006). A gain-of-function variant of
PTPN22 has been shown to reduce T cell sensitivity
(Vang et al., 2005). Consistent with the role of PTPN22
as a negative regulator of Lck, we found an increase in
Y394 phosphorylation of Lck in miR-181a T cells even be-
fore stimulation (Figure 4A). DUSP5 and DUSP6, which
have different cellular localization, can specifically inacti-
vate ERK1/2 by dephosphorylating the T202 and Y204
residues in the nucleus and cytosol, respectively (Theodo-
siou and Ashworth, 2002). SHP-2 was found to mediate
negative costimulatory signals elicited by CTLA-4 (Maren-
gere et al., 1996), but it has not been shown to play any di-
rect role in TCR proximal signaling (Salmond et al., 2005).
To examine how miR-181a may affect ERK1/2 activa-
tion, we measured ERK1/2 T202 and Y204 phosphoryla-
tion (ppERK) levels before and after antagonist stimulation
using intracellular antibody staining and FACS analysis
(Krutzik and Nolan, 2003). miR-181a T cells have a signifi-
cantly higher level of ppERK prior to stimulation (Figure 4B,
blue lines). MCC 99R can stimulate ERK phosphorylation
in miR-181a T cells (Figure 4B) or in DP thymocytes, which
have a naturally high level of miR-181a (Figure 7C), but not
in control T cells (Figure 4B, orange lines). Furthermore,
we examined whether miR-181a may alter the kinetics
of ERK phosphorylation during T cell activation. T cells
were activated by CD33 crosslinking to avoid any contri-
bution from costimulation. We noted that miR-181a T cells
have a significantly higher basal level of ppERK before
stimulation and a slightly higher peak level after stimula-
tion (Figure 4C). While both the control and miR-181a T
cells reached maximal levels within 15 min after stimula-
tion, a delay in dephosphorylation was observed in
miR-181a T cells. More importantly, ppERK in these cells
returns to a higher basal level when compared to controls
(Figure 4C, time points 15–60 min). These data demon-
strate that ERK phosphorylation is shifted to a higher basal
level both before and after stimulation, suggesting that
miR-181a induces decreases in phosphatase expression
and acts to shift the equilibrium to higher steady-state
levels of ppERK.
This increased basal level of ppERK may have addi-
tional effects in potentiating TCR proximal signaling asindicated by dramatic increases in serine phosphorylation
of Lck in miR-181a T cells (Figure 4D). Restoring DUSP6
expression to a normal level by coexpressing miR-181a
and a DUSP6 gene without the miR-181a target sites (Fig-
ure 6A) reduces basal Lck serine phosphorylation to the
background level (Figure 4D), suggesting that the downre-
gulation of DUSP6 is directly responsible for the increase
in Lck serine phosphorylation. While there are four major
serine phosphorylation sites in Lck, activated ERK is re-
sponsible for Ser59 phosphorylation under physiological
conditions (Winkler et al., 1993). Germain and colleagues
have proposed that positive feedback from ERK is crucial
for agonists to overcome SHP-1 blockade and have
shown that Ser59 phosphorylation of Lck can block
SHP-1 recruitment (Stefanova et al., 2003). In agreement
with this observation, we noted a dramatic reduction in
the recruitment of SHP-1 to Lck before and after antago-
nist stimulation in miR-181a T cells (Figure 4E). It is also
notable that restoring DUSP6 expression in these cells re-
sults in a decrease in the basal level of Y394 phosphoryla-
tion on Lck, suggesting that blocking SHP-1 recruitment
to Lck may also contribute to the increased basal level
of this phosphotyrosine (Figure 4A). These observations
suggest an alternative mechanism in which antagonist-
induced SHP-1 negative feedback can be overcome or re-
duced despite the fact that SHP-1 is not directly targeted
by miR-181a. Collectively, it seems that the increased
basal level of Lck and ERK activation in miR-181a T cells
reduces the amount of signal that is required for achieving
full Lck and ERK activation upon antigen stimulation, thus
reducing the activation threshold and increasing signaling
strength to agonists and antagonists (Figure S11).
Multitarget Regulation by miR-181a Is Crucial
for Its Function
To determine whether one or all of the phosphatases reg-
ulated by miR-181a are functionally relevant for its conver-
sion of antagonists into agonists, we designed short hair-
pin siRNAs (shRNAs) to selectively ‘‘knock down’’ SHP-1,
SHP-2, DUSP5, and DUSP6 expression (Figures 5A and
5B). In each case, we were able to obtain shRNA con-
structs that can specifically repress target gene expres-
sion equally or more efficiently than miR-181a (Figures
3B, 5A, and 5B). We then expressed individual shRNAs
in T cells by viral transduction and challenged them with
APCs preloaded with MCC 99R. We determined the cal-
cium response and then categorized the signal strength
using the typical response of control T cells toward MCC
as a reference. As shown in Figure 5C, over 90% of
miR-181a T cells yielded medium to strong responses
when stimulated with MCC 99R, whereas less than 10%
of the T cells infected with shRNAs against DUSP5,
SHP-2, control shRNAs, or control virus (Figure 5C) re-
sponded this way, which represents the background
levels. We noticed that shRNAs against SHP-1 and
DUSP6 do have modest effects, with 25% and 38% of
the T cells expressing shRNA yielding medium to strong
responses, respectively. However, both the peak valuesCell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 153
Figure 4. miR-181a Increases the Basal Phosphorylation Levels of Lck and ERK
(A) Western blot analyses of anti-Lck immunoprecipitates to detect site-specific phosphorylation. Phosphorylation of Lck at the activating Y394
or inhibitory Y505 before antigen stimulation was probed. Lck phosphorylation was also analyzed in miR-181a T cells with restored DUSP6 or
SHP-2 expression. Membranes were stripped and reprobed for Lck as loading controls.
(B) Induction of ERK phosphorylation by the antagonist MCC 99R (10 mM loading and 5 min stimulation). Cells were gated on GFP+CD4+ to identify
virally infected T cells and analyzed for ppERK by Phosphoflow.
(C) Effects of miR-181a on the kinetics of ERK phosphorylation upon T cell stimulation by anti-CD33 crosslinking.
(D) Western blot analyses of anti-Lck immunoprecipitates to detect Lck serine phosphorylation before antigen stimulation.
(E) miR-181a expression inhibits the Lck and SHP-1 interaction. T cells were stimulated by peptide preloaded APCs (10mM MCC 99R or 1mM MCC) for
5 min. SHP-1 was coprecipitated with Lck whereas SHP-2 was undetectable under the same condition.and the degree to which calcium signaling is sustained are
reduced even in these T cells when compared to the
response in miR-181a T cells (Figure S7). Taken together,
these data demonstrate that repressing individual phos-
phatases is not sufficient to fully reproduce the
miR-181a phenotype in T cells.154 Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc.To evaluate whether downregulation of individual
miR-181a targets is necessary for the increase in T cell
sensitivity to antagonists, we restored DUSP6 expression
to normal levels in miR-181a T cells by expressing a
DUSP6 gene that lacks the miR-181a target sites (Fig-
ure 6A). This resulted in a reduction in the basal level of
Figure 5. Multitarget Repression Is
Required for miR-181a Function in TCR
signaling
(A and B) The efficacy and specificity of shRNA
constructs that were designed to target
DUSP6, SHP-2, SHP-1, and (B) DUSP5,
respectively, as determined by western blot
analyses.
(C) Calcium responses to antagonist MCC 99R
stimulation in T cells ectopically expressing
miR-181a or shRNAs against individual
miR-181a targets. Both the strength of calcium
response and percentage of T cells activated
were measured and summarized. Integrated
calcium flux during the first 5 min after activa-
tion was used to evaluate the strength of TCR
signaling. T cells with continuous calcium ele-
vation at 50% above the baseline (designated
as 1) for 1 min were designated as activated T
cells. Integrated calcium ratio was arbitrarily
categorized and color-coded using the re-
sponse of control T cells to agonist MCC as
a reference (<2, no response; 2–8.0, weak re-
sponse; 8.0–12.0, medium response; >12.0,
strong response).ppERK (Figure 6B, time point zero) and accelerated ERK
dephosphorylation/inactivation (Figure 6B, time points
10–60 min). Most importantly, restoring DUSP6 expres-
sion in this way completely abolishes T cell reactivity to
MCC 99R (Figures 6C, 6D, and 6E; Movie S6). Similarly,
restoring DUSP5 expression in the nucleus (Figure S8A)
results in a dramatic reduction in the IL-2 production in-
duced by MCC 99R, while it has little effect on cytosolic
calcium responses (Figures 6D and 6E; Movie S7), sug-
gesting that wild-type DUSP5 acts as a negative regulator
controlling IL-2 production in the nucleus with little impact
on immediate early TCR signaling. Interestingly, express-
ing and sequestering DUSP5 protein in the cytosol by
nuclear localization signal mutation (Mandl et al., 2005)
largely resembles the TCR sensitivity shift caused by re-
storing DUSP6 (Figures 6D and 6E). These data collec-
tively suggest that the cytosolic level of ERK activation
may be crucial for initial TCR signaling upon antigen rec-
ognition. In contrast, restoring SHP-2 (Figure S8B) does
not change the basal level of Lck activation (Figure 4A)or suppress the recognition of MCC 99R, although it
does cause a modest reduction in TCR signaling strength
(Figure 6D; Movie S8), suggesting that SHP-2 plays a mi-
nor role in antigen discrimination. These results demon-
strate that the TCR signaling threshold is controlled by
multiple phosphatases at distinct steps of the down-
stream pathways, albeit with varied contributions to the
threshold.
Antagomir-181a Dampens T Cell Sensitivity
and Impairs Positive and Negative Selection
The above results clearly show that increasing miR-181a
levels in mature T cells by ectopic expression augments
T cell sensitivity. To test whether reducing the level of en-
dogenous miR-181a affects T cells reciprocally, we used
antagomir—antisense oligos that silence miRNA expres-
sion in vivo (Krutzfeldt et al., 2005)—to reduce miR-181a
expression. We find that antagomir-181a significantly
lowers naı¨ve T cell sensitivity to MCC and MCC 102S, as
indicated by calcium flux and IL-2 production (FiguresCell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 155
Figure 6. The Contribution of Individual Phosphatases on Antigen Discrimination
(A) Western blot analysis demonstrates restored DUSP6 expression.
(B–E) Abolishing T cell reactivity to MCC 99R by restoring DUSP6 expression in miR-181a T cells. In (B), restoring DUSP6 expression is sufficient to
override the effects of miR-181a on the basal level and poststimulation kinetics of ERK phosphorylation. The gray line marks the basal level of ERK156 Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc.
S9B and S9C) and expression of CD69 and CD5, two sur-
face markers for early T cell activation (data not shown).
Reducing miR-181a expression also dampens T cell sen-
sitivity to weak stimulation in primed T cells, albeit to
a lesser degree than that in naı¨ve cells (Figures S9D and
S9E). The smaller reduction in antigen sensitivity in primed
T cells is probably because the miR-181a level in these
cells (10 copies/cell) is much lower than that in the naı¨ve
T cells (30 copies/cell) (Figure 1A). Finally, a maximal re-
sponse to the agonist MCC can be induced at a loading
concentration close to the peptide: MHC Kd in naı¨ve T
cells (Figure S9B), while much higher concentrations are
required to elicit a maximal response in primed T cells,
suggesting that naı¨ve T cells are more sensitive to antigen,
consistent with recent peptide response studies (M. Huse,
M.Kuhns, and M.D., unpublished data).
miR-181a expression is dynamically regulated during
T cell development, with immature DP cells having a
10-fold higher expression of miR-181a than their mature
counterparts (Figure 1A). This higher miR-181a expression
correlates with heightened sensitivity toward pMHC li-
gands in DP cells, which is thought to be critical in ensur-
ing proper positive and negative selection, and shaping of
the mature T cell repertoire (Davey et al., 1998). Conse-
quently, we tested miR-181a function in DP cell selection
using fetal thymic organ culture (FTOC) with or without an-
tagomir treatment. We crossed 5C.C7 TCR transgenic
mice onto an invariant chain knockout (Ii/) background
(Bodmer et al., 1994) to arrest thymocytes at the DP stage.
Presenting exogenous 5C.C7 TCR antigens, such as ago-
nist (MCC), weak agonist (MCC 102S, data not shown), or
antagonist (MCC 99R), can induce efficient negative se-
lection within 48 hr, and introducing antagomir-181a to
these cultures results in a greater than 50% inhibition (Fig-
ure 7A). Although a moderate increase in the DN cell pop-
ulation was observed, antagomir-181a treatment did not
affect the viability of DP thymocytes in this culture system
(Figure 7A; data not shown). To examine the role of miR-
181a in positive selection, we used thymi from wild-type
5C.C7 embryos. These mice have normal invariant chain
production and are capable of presenting endogenous
peptide antigens, thus allowing positive selection. Damp-
ening miR-181a expression with the antagomir-181a
reagent substantially impairs positive selection, reducing
the number of mature CD4+ SP thymocytes by70% (Fig-
ure 7B). Further confirming that the miR-181a level in thy-
mocytes plays a critical role in their activation, the respon-
siveness of 5C.C7 DP cells to MCC and MCC 102S, as
indicated by CD69 expression, was almost abolished by
treatment with 50 mg/ml antagomir-181a (Figure S10A).With respect to the mechanism of this inhibition in
thymocytes, all miR-181a-targeted phosphatases are
expressed in DP cells, and antagomir-181a treatment
increases the mRNA and protein levels of PTPN22, SHP-
2, DUSP5, and DUSP6 (Figures S10B and S10C). Consis-
tent with the increased expression of those phosphatases
in antagomir-181a treated DP cells, we observed a severe
reduction of ERK activation both in basal level (Figure 7C;
time 0) and antigen-induced phosphorylation (Figure 7C;
time 50 to 600). Collectively, these results demonstrate
that antagomir-mediated reduction of miR-181a expres-
sion in immature DP cells attenuates their sensitivity to
antigen and inhibits positive and negative selection.
Thus, miR-181a is an intrinsic modulator of TCR sensitivity
during T cell development and function.
DISCUSSION
Our studies demonstrate that TCR sensitivity and signal-
ing strength can be modulated at the posttranscriptional
level by miR-181a. These findings have a number of impli-
cations for both the regulation of the adaptive immune re-
sponse and the biology of miRNAs. In particular, these
data suggest that miR-181a is a rheostat governing T
cell sensitivity. It is known that the same antigenic pep-
tides elicit distinct TCR signals and responses in T cell
populations at different developmental stages, suggesting
that T cell sensitivity to antigens is intrinsically regulated
(Pircher et al., 1991; Davey et al., 1998). Properly tuning
T cell sensitivity at various developmental stages may be
critical for regulating the development of tolerance and
effector cell function. miR-181a expression is higher in im-
mature T cell populations that recognize low-affinity self-
antigens, such as DP thymocytes, but lower in the more
differentiated T cell populations that are only reactive to
relatively high-affinity foreign antigens, such as Th1 and
Th2 effector cells (Figure 1A). The inhibition of this miRNA
by antagomor-181a significantly impairs DP cell sensitivity
and efficiently obstructs positive and negative selection,
supporting the notion that miR-181a is developmentally
regulated to refine T cell sensitivity. Interestingly, miR-
181a is also highly expressed in DN3 cells that are under-
going the selection driven by self oligomerization of pre-
TCRs (Yamasaki et al., 2006), which is presumably
a weak stimulation that miR-181a may help to potentiate.
The modulation of selection also argues that miR-181a
might directly impact the mature T cell repertoire, which
might further affect the onset and/or progression of T
cell autoimmunity. Together, these results demonstrate
that miRNAs may represent a novel class of regulatoryactivation in control cells, and the brown line indicates the full activation level of ERK in control T cells upon TCR activation. In (C) are overlaid DIC and
calcium images taken at various time points after T cells ectopically expressing miR-181a alone (top panel) or miR-181a and DUSP6 together (lower
panel) were stimulated with APCs preloaded with MCC 99R (20 mM). Shown in (D) is cytosolic calcium concentration as a function of time in T cells
ectopically expressing miR-181a alone or miR-181a together with individual target phosphatases. Shown in (E) is the effect of individual target res-
toration on IL-2 production. Virally infected and selected T cells were set to rest after initial preparation, then cocultured with g-irradiated APCs pre-
loaded with either MCC 99A (20 mM), MCC 99R (10 mM), or MCC 102G (20 mM). Supernatants were collected at 24 hr after stimulation and analyzed for
IL-2 production by ELISA ([IL-2] ± SD, n = 3).Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 157
Figure 7. miR-181a Modulates Positive and Negative Selection
(A) Antagomir-181a (Ant181a) impairs negative selection. E17 fetal thymi from 5C.C7 TCR transgenic mouse embryos on an Ii/B10BR background
were used to set up FTOC assays. Antagomir-181a (50 mg/ml) or PBS mock control was applied upon initiation of the culture. MCC (100 nM), MCC
99R (5mM), or PBS was introduced 24 hr later. Cultured thymi were analyzed 48 hr after peptide application. Representative data of six independent
replicates are shown.
(B) Antagomir-181a impairs positive selection. FTOC was performed with thymi dissected from e15 or e16 5C.C7 wild-type embryos (absent of SP
cells, data not shown) and antagomir-181a (50 mg/ml) or the mock control was applied upon culture initiation. Thymocytes were analyzed 4–5 days
later. CD69 and CD62L staining was also used to verify the postselection phenotype of SP cells (data not shown). Representative data of six replicates
are shown.
(C) Antagomir-181a inhibits ERK activation in DP thymocytes. DP cells prepared from the thymus of adult 5C.C7 Ii/ mice were stimulated with
CH27 cells served as APC loaded with 10 mM MCC 99R (green/red) or PBS (gray).158 Cell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc.
molecules that can modulate T cell sensitivity. However,
we do not exclude the possibility that other TCR signaling
components or other miRNAs may also contribute to
changes in sensitivity.
Our findings also provide new insights into the signaling
pathways that determine how TCRs sense quantitative
differences in antigen affinity and elicit quantitatively and
qualitatively different responses, and how such responses
may be intrinsically tuned. These observations suggest
that the TCR and its proximal signaling molecules act as
a ‘‘signal integrator’’ to sum up the positive and negative
signals elicited by antigen stimulation, thus determining
the outcome of TCR engagement. It is known that, in gen-
eral, longer half-life pMHC ligands elicit stronger positive
signals. We find here that the negative feedback signals
in this pathway, controlled in part by multiple phospha-
tases downstream of the TCR, play a key role in regulating
TCR signaling and antigen discrimination, suggesting that
they set an ‘‘excitation threshold’’ for T cell activation, in
which negative regulation is likely to be dominant. Sup-
porting this, primed T cells normally cannot be activated
by antagonist pMHCs (Figures 2 and 4), suggesting that
these ligands cannot generate sufficient positive signals
to overcome the excitation threshold. However, when
the equilibrium is shifted toward a higher steady state of
phosphorylated signaling intermediates (ERK1/2, Lck as
shown above) by ectopically expressing miR-181a (Fig-
ure 2 and 4), these ligands are now stimulatory, and
weak agonists are now strongly activating (Figure S11).
One would also predict that dampening these negative
signals should lead to an increase in TCR signaling
strength, since the degree of positive signaling required
for overcoming the excitation threshold is also reduced. In-
deed, we have shown that antagonist, or weak agonist, or
agonist I-Ek complexes have increased signaling strength
in miR-181a T cells, albeit at quantitatively different levels
(Figures 1 and 2). Our findings also suggest two avenues
that can be used to overcome this excitation threshold
and to activate T cells. One is by reducing the excitation
threshold such that it can be overcome by the otherwise in-
sufficient positive signals generated from a particular weak
antigen. Alternatively, weak positive TCR signals may be
potentiated so that the excitation threshold can be over-
come. Finally, our finding that antagonists can be con-
verted into agonists shows that even antagonists can
bind to the TCR long enough to complete the entire TCR
signaling cascade when the threshold is reduced.
Many biological processes are controlled at the sys-
tems level by coordinated regulation of networks of genes.
Specifically, TCR signaling and antigen recognition are
controlled by sequential phosphorylation and dephos-
phorylation events in a spatially and temporally ordered
manner (Kane et al., 2000). T cells express more than 40
different tyrosine phosphatases and other known or un-
known negative regulators of TCR signaling (Mustelin
et al., 2005). There are multiple phosphatases for each
of the key kinases, such as Lck, ZAP70, ERK, etc. (Muste-
lin et al., 2005). Tuning a T cell’s excitation threshold pres-ents a particular challenge because of the many signaling
molecules that seem to constitute the threshold. It may
require the coordinate regulation of multiple negative reg-
ulators that share little or no sequence homology. Our
findings demonstrate that this task can be carried out
very efficiently by a single miRNA, which can regulate mul-
tiple targets, but not by a single shRNA, which is designed
to target individual genes. This is consistent with the no-
tion that each miRNA can potentially regulate hundreds
of targets (Krek et al., 2005; Lewis et al., 2005). Neverthe-
less, the function of most miRNAs with known biological
roles has been attributed to the regulation of a single tar-
get gene (Ambros, 2003), and the biological significance
of multitarget regulation by miRNAs in signaling is unclear.
We have also shown that the expression of PTPN22, SHP-
2, and DUSP6 are only modestly reduced by miR-181a
(Figure 3), suggesting that quantitative regulation is suffi-
cient to allow a discriminative switch during antigen rec-
ognition. Finally, we have noted that miR-181a is likely to
have other roles in T cell function, since it also influences
the costimulatory pathway through as yet unknown tar-
gets (Figure S4). Collectively, our findings suggest that
miRNAs may be evolutionarily selected gene-regulatory
molecules that can carry out integrated biological func-
tions by regulating gene networks posttranscriptionally
(Bartel and Chen, 2004).
EXPERIMENTAL PROCEDURES
Details of standard techniques, mouse strains, antibodies used, and se-
quences can be found in the Supplemental Experimental Procedures.
T Cells and APCs
T cells were harvested from the lymph nodes of 5C.C7 mice and
primed with 10 mM MCC peptide. A day after priming, T cells were
transduced with retroviral miRNA expressing constructs (Figure S2).
Infected T cells were first subjected to blasticidin (12.5 mg/ml, Invitro-
gen) selection for 2 days starting at 36 hr postinfection, further
enriched by density gradient centrifugation with Histopaque-1119
(Sigma-Aldrich), and finally purified based on H-2Kb expression by
magnetic bead sorting according to the manufacturer’s protocol (Bio-
tinylated anti-H-2Kb, 10 mg/ml, BD Pharmingen; CELLection Biotin
Binder Kit, Dynal Biotech). With this procedure, infected T cells were
enriched to at least 95% purity based on FACS analyses (data not
shown). Peptide-loaded CH27 cells, a mouse B lymphoma cell line,
were used as antigen presenting cells in this study.
Quantitative PCR for miRNA Expression Analysis
The ABI TaqMan miRNA assays were used to measure miR-181a
expression in various T cell populations (Chen et al., 2005). Purified
T cells were spiked with a synthetic miRNA standard at a fixed ratio
of pmol/cell. Total RNA samples were then prepared using Trizol
reagents. miRNA expression in each cell population was determined
using standard curve methods following the ABI TaqMan miRNA quan-
titative PCR protocol.
Multichannel Time-Lapse Microscopy and Data Analysis
Calcium imaging and synaptic peptide quantification were performed
on a Zeiss Axiovert-100TV station equipped with a CoolSNAPHQ
CCD camera (Roper Scientific) as described (Li et al., 2004), also in
Supplemental Experimental Procedures. The data points were pooled
from four batches of primary cell preparation. For calcium dynamicsCell 129, 147–161, April 6, 2007 ª2007 Elsevier Inc. 159
and concentration integration analysis in activated T cells, time 0 was
defined as the time point prior to the first 20% increase of ratioed
fluorescent intensity, then the base line (value = 1.00) was drawn by
averaging the intensity before time 0. In inactive T cells, time 0 was
arbitrarily assigned as the T:APC contact point observed in the differ-
ential interference contrast (DIC) channel. The integrated value of cyto-
solic calcium elevation was generated by summing up the changes in
relative calcium concentration at each time point within the first 5 min
of T cell calcium response.
Luciferase Reporter Assay for Target Validation
NIH-3T3 cells stably expressing miR-181a on miR-181amut were gen-
erated by viral transduction and multiple rounds of blasticidin selection
and then transfected with 0.1 mg of firefly luciferase reporter vector to-
gether with 0.025 mg of control Renilla luciferase control vector (see
Figure S2B) using FuGene 6 reagents (Roche). Cells were lysed at 48
or 72 hr after transfection and analyzed for firefly and Renilla luciferase
activities using the Dual-Luciferase Assays (Promega) on a Veritas
Microplate Luminometer.
Antagomir Treatment
Antagomirs were synthesized as described (Krutzfeldt et al., 2005). For
naı¨ve T cell transfection, cells were cultured for 16 hr in the presence of
5 ng/ml IL-7 and 50 mg/ml antagomir-181a or Mm-antagomir-181a; for
DP thymocyte transfection, cells were cultured in RPMI medium for
12 hr in the presence of various amounts of antagomir-181a.
Fetal Thymic Organ Culture
Thymi were dissected from e15 embryos of 5C.C7 TCR mice or e17 em-
bryos of 5C.C7 TCR Ii/ mice. Fetal thymi were cultured on 0.8 micron
filters (Millipore) and MF support pads (Millipore) floated on RPMI culture
medium. Antagomirs were added to thymi at a final concentration of
50 mg/ml on day 0 of culture, antigenic peptides were added on day 1,
and single cell suspensions were prepared for FACS analysis on
days 3–5.
Phosphoflow Analysis
Phosphoflow technology was used to monitor T202 Y204 phosphory-
lation of ERK1/2 (ppERK) (Krutzik and Nolan, 2003). Briefly, virally in-
fected T cells were mixed with CH27 cells alone or CH27 cells pre-
loaded with 10 mM MCC 99R, spun down to facilitate rapid T:APC
contact, incubated at 37C for 5 min or with anti-CD33 crosslinking
at various time points, and fixed with 2% paraformaldehyde at room
temperature for 20 min. After washes with ice-cold FACS buffer
(PBS pH 7.4, 2mM EDTA, 2% FBS), T cells were blocked with anti-
CD16/CD32 (10 mg/ml) for 15 min on ice and stained with fluorescent
antibodies against the cell surface markers CD4, CD28, etc. After be-
ing washed three times with FACS buffer, T cells were suspended in
90% ice-cold methanol and kept on ice for 30 min to allow for perme-
abilization. One million permeabilized cells were further blocked by
anti-CD16/CD32 and species-matched serum, stained with phos-
phor-specific ERK antibody, and analyzed by FACS (Cytomics
FC500, Beckman Coulter). FACS data was analyzed with FlowJo soft-
ware (Tree Star, Inc.). The ppERK staining results were repeated with
an indirect staining approach using anti-ppERK rabbit monoclonal an-
tibody (Cell Signaling Technology), followed by donkey Cy5-anti-rabbit
IgG staining (Jackson ImmunoResearch) and FACS analysis.
Supplemental Data
Supplemental Data include 11 figures, 8 movies, and Supplemental
Experimental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/129/1/147/DC1/.
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